Halozyme Therapeutics, Inc. (NASDAQ:HALO) appears in 595 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 293,658 | 2.28% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | -62,890 | -0.54% | $0.00 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 1,842,956 | 0.00% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -377,398 | -61.45% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 102,465 | 2.04% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -1,580,108 | -53.64% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 158,325 | 2,504.75% | $0.00 |
| Invesco Ltd. | 31 Dec, 2025 | 0 | 402,293 | 12.39% | $0.00 |
| MIZUHO MARKETS AMERICAS LLC | 31 Dec, 2025 | 0 | 926,526 | 270.80% | $0.00 |
| World Investment Advisors | 31 Dec, 2025 | 0 | 20,028 | 0.00% | $0.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Dec, 2025 | 0 | -68,158 | -2.07% | $0.00 |
| Pacer Advisors, Inc. | 31 Dec, 2025 | 0 | 458,419 | 95.73% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 6,532 | 140.78% | $0.00 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 31 Dec, 2025 | 0 | 1,387,966 | 101.22% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | 46,770 | 7.16% | $0.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 0 | -1,218,540 | -30.83% | $0.00 |
| Squarepoint Ops LLC | 31 Dec, 2025 | 0 | 55,573 | 15.53% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | 920,699 | 52.99% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | -188,855 | -31.41% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 1,914 | 0.08% | $0.00 |